PAVmed Inc. financial data

Symbol
PAVM, PAVMZ on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Madison Avenue, 25 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
PAXmed Inc. (to 3/26/2015)
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 43.2 % -50.9%
Quick Ratio 0.69 %
Debt-to-equity -106 % +46.4%
Return On Equity -134 % +97.6%
Return On Assets 69.3 %
Operating Margin -1.38K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11M shares -90.9%
Common Stock, Shares, Outstanding 10.7M shares -91.1%
Entity Public Float 38.6M USD -45.2%
Common Stock, Value, Issued 11K USD -90.8%
Weighted Average Number of Shares Outstanding, Basic 10M shares +34.1%
Weighted Average Number of Shares Outstanding, Diluted 44.5M shares +496%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1M USD
Revenue from Contract with Customer, Excluding Assessed Tax 4.03M USD +25.9%
Cost of Revenue 6.4M USD -0.44%
Research and Development Expense 8.72M USD -49.1%
Selling and Marketing Expense 16.2M USD -13.4%
General and Administrative Expense 27.4M USD -20.2%
Costs and Expenses 59.7M USD -24%
Operating Income (Loss) -55.7M USD +27.7%
Nonoperating Income (Expense) 72.3M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9.88M USD
Net Income (Loss) Attributable to Parent 24.3M USD
Earnings Per Share, Basic 6.43 USD/shares
Earnings Per Share, Diluted -4.27 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 765K USD -97.1%
Accounts Receivable, after Allowance for Credit Loss, Current 16K USD -55.6%
Inventory, Net 6K USD
Assets, Current 2.13M USD -93.4%
Property, Plant and Equipment, Net 216K USD -88.1%
Operating Lease, Right-of-Use Asset 2.62M USD -43.9%
Intangible Assets, Net (Excluding Goodwill) 947K USD -61.1%
Other Assets, Noncurrent 75K USD -93.5%
Assets 30.6M USD -27.3%
Accounts Payable, Current 465K USD -78.5%
Employee-related Liabilities, Current 2.51M USD +29.2%
Accrued Liabilities, Current 4.54M USD -17.2%
Liabilities, Current 37.6M USD -31.1%
Operating Lease, Liability, Noncurrent 2.38M USD -28.8%
Liabilities 39.9M USD -31%
Retained Earnings (Accumulated Deficit) -256M USD +7.98%
Stockholders' Equity Attributable to Parent -4.87M USD +88.7%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -9.39M USD +40.7%
Liabilities and Equity 30.6M USD -27.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +19.9%
Net Cash Provided by (Used in) Financing Activities 19M USD -23.6%
Net Cash Provided by (Used in) Investing Activities -42K USD -104%
Common Stock, Shares Authorized 50M shares -80%
Common Stock, Shares, Issued 94.5M shares +9.43%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.9M USD -38.2%
Deferred Tax Assets, Valuation Allowance 93.6M USD +62.8%
Deferred Tax Assets, Gross 94.8M USD +62.5%
Operating Lease, Liability 2.88M USD -41.4%
Depreciation 93K USD +675%
Payments to Acquire Property, Plant, and Equipment 42K USD +61.5%
Lessee, Operating Lease, Liability, to be Paid 3.52M USD -40.3%
Property, Plant and Equipment, Gross 3.5M USD +7.46%
Operating Lease, Liability, Current 499K USD -68.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 724K USD -13.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 708K USD -61.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 640K USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 594K USD -24.5%
Deferred Tax Assets, Operating Loss Carryforwards 67.8M USD +83%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 471K USD -23.7%
Operating Lease, Payments 476K USD +37.6%
Additional Paid in Capital 248M USD +6.88%
Amortization of Intangible Assets 1.07M USD -47.3%
Depreciation, Depletion and Amortization 586K USD -19.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%